165.85
1.60%
2.54
전일 마감가:
$163.31
열려 있는:
$162.77
하루 거래량:
1.75M
Relative Volume:
0.80
시가총액:
$74.09B
수익:
$9.15B
순이익/손실:
$2.43B
주가수익비율:
31.17
EPS:
5.32
순현금흐름:
$2.31B
1주 성능:
+2.27%
1개월 성능:
-5.97%
6개월 성능:
-5.17%
1년 성능:
-14.85%
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
ZTS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
165.92 | 74.09B | 9.15B | 2.43B | 2.31B | 5.32 |
HLN
Haleon Plc Adr
|
9.465 | 42.86B | 14.26B | 1.55B | 0 | 0.3383 |
TAK
Takeda Pharmaceutical Co Adr
|
13.31 | 42.09B | 30.27B | 1.93B | 3.45B | 0.6044 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.98 | 24.09B | 16.77B | -959.00M | 1.37B | -0.85 |
VTRS
Viatris Inc
|
11.95 | 14.56B | 15.05B | -883.30M | 1.89B | -0.74 |
조에티스 Stock (ZTS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-02 | 개시 | Leerink Partners | Outperform |
2024-07-25 | 개시 | BTIG Research | Buy |
2024-01-12 | 재확인 | Stifel | Buy |
2023-12-19 | 재개 | Jefferies | Buy |
2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
2023-09-06 | 개시 | HSBC Securities | Buy |
2022-07-12 | 개시 | Piper Sandler | Overweight |
2021-11-18 | 개시 | Morgan Stanley | Overweight |
2021-08-05 | 재개 | Credit Suisse | Outperform |
2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2020-09-21 | 개시 | Atlantic Equities | Overweight |
2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
2020-05-27 | 개시 | Jefferies | Buy |
2020-01-10 | 개시 | Raymond James | Mkt Perform |
2019-09-09 | 개시 | Goldman | Buy |
2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2019-06-11 | 개시 | Barclays | Overweight |
2019-05-23 | 개시 | Guggenheim | Buy |
2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
2019-03-20 | 개시 | SunTrust | Hold |
2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
2019-01-23 | 개시 | UBS | Neutral |
2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
2018-08-03 | 재확인 | Stifel | Buy |
2018-04-19 | 재확인 | Citigroup | Buy |
2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2018-02-16 | 재확인 | Stifel | Buy |
2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
AHP launches sixth equine industry survey, sponsored by Zoetis - EQUUS Magazine
Pensionfund Sabic Has $1.83 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Nordea Investment Management AB Buys 572,511 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Equine Healthcare Market Size, Competitive Outlook Zoetis, Kyoritsu Seiyaku, Vetoquinol, Boehringer Ingelheim, Virbac - openPR
Pet Health Screening Market Future Business Opportunities - openPR
Everence Capital Management Inc. Reduces Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Wrap up: Artificial intelligence and its role in veterinary medicine, and other veterinary news - DVM 360
Zoetis Inc. stock rises Friday, still underperforms market - MarketWatch
GAMMA Investing LLC Acquires 3,165 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
AHP Launches Sixth Equine Industry Survey, Sponsored by Zoetis - TheHorse.com
Zoetis to Acquire Animal Health Assets of Abbott - Farm Progress
GeneDx appoints former Zoetis general counsel as legal chief - | Governance Intelligence
Zoetis (ZTS) is a Top-Ranked Growth Stock: Should You Buy? - MSN
Is Zoetis Inc. (ZTS) the Best Pharma Dividend Stock to Buy In 2024? - Insider Monkey
13 Best Pharma Dividend Stocks To Buy In 2024 - Insider Monkey
Pet Medication Market Projected To Witness Substantial Growth, 2024-2031: Zoetis, Merck, Elanco, Bayer, - EIN News
JPMorgan Chase & Co. Grows Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
ZTS: Is Zoetis a Smart Investment in the Pharmaceuticals Sector? - StockNews.com
ZTS: 3 Healthcare Innovators with Analyst-Endorsed Upside - StockNews.com
Zoetis Inc. (ZTS): A Bull Case Theory - MSN
The Wall Street Journal Vs. Zoetis (ZTS) - Seeking Alpha
Zoetis Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zoetis Inc. (NYSE:ZTS) Shares Sold by M&T Bank Corp - MarketBeat
Here's Why Zoetis (ZTS) Gained But Lagged the Market Today - MSN
Livestock Drug Market to See Stunning Growth with Zoetis, Elanco, Bayer Animal Health - openPR
Zoetis Inc. (NYSE:ZTS) Receives $215.22 Consensus PT from Brokerages - MarketBeat
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zoetis is Now Oversold (ZTS) - Nasdaq
📈 Is Zoetis a good stock to buy? - substack.com
Earnings growth of 2.9% over 3 years hasn't been enough to translate into positive returns for Zoetis (NYSE:ZTS) shareholders - Simply Wall St
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income - The Motley Fool
Zoetis dips as FDA cites adverse events linked to canine pain therapy Librela - MSN
Zoetis donates $100,000 to support vet mental health - Vet Practice magazine
Elliott Wave Pattern Puts Zoetis Bulls On Alert - EWM Interactive
Zoetis stock dips after FDA notice on Librela (ZTS:NYSE) - Seeking Alpha
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet? - Yahoo Finance
Zoetis Issues Vaccine Reminder for Pregnant Broodmares in Third Trimester - EQUUS Magazine
Here's Why Zoetis (ZTS) is a Strong Growth Stock - Yahoo Finance
American Trust Sells 4,044 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Wilmington Savings Fund Society FSB Increases Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
World Investment Advisors LLC Has $6.69 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Stake Lessened by Sanctuary Advisors LLC - MarketBeat
Podcast: Harness Culture to Drive Value with Zoetis’ Supply Chain EVP - Gartner
Zoetis Boosts Dividend by 16% for 2025 - TipRanks
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase - Business Wire
Stock Yards Bank & Trust Co. Lowers Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Toronto Dominion Bank Increases Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Veterinary Pain Management Market Is Booming Worldwide - openPR
Zoetis Boosts Quarterly Dividend by 16% to Record $0.50, Showcases Strong Financial Performance - StockTitan
Why Zoetis Inc. (NYSE:ZTS) Looks Like A Quality Company - Yahoo Finance
TCW Group Inc. Has $123.40 Million Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):